Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Axim Biotech (AXIM)
:AXIM
AXIM Stock Chart & Stats
Day’s Range― - ―
52-Week Range<$0.01 - $0.02
Previous CloseN/A
Volume359.42K
Average Volume (3M)606.53K
Market Cap
$966.27K
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta-1.00
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding301,958,830
10 Day Avg. Volume170,903
30 Day Avg. Volume606,532
Standard Deviation0.48
R-Squared0.01
Alpha-0.00704
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)10.40
Price to Cash Flow (P/CF)0.40
P/FCF Ratio0.30
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
AXIM Biotechnologies News
PremiumCompany Announcements
AXIM Biotechnologies Resolves Dispute, Issues Equity---
Options Prices
Currently, No data available
---
Ownership Overview
9.77% Insiders
―
Mutual Funds
― Other Institutional Investors
90.23% Public Companies and
Individual Investors
AXIM FAQ
What was Axim Biotech’s price range in the past 12 months?
Axim Biotech lowest stock price was <$0.01 and its highest was $0.02 in the past 12 months.
What is Axim Biotech’s market cap?
Axim Biotech’s market cap is $966.27K.
When is Axim Biotech’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Axim Biotech’s earnings last quarter?
Axim Biotech released its earnings results on Aug 22, 2017. The company reported -$0.01 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.01.
Is Axim Biotech overvalued?
According to Wall Street analysts Axim Biotech’s price is currently Overvalued.
Does Axim Biotech pay dividends?
Axim Biotech does not currently pay dividends.
What is Axim Biotech’s EPS estimate?
Axim Biotech’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Axim Biotech have?
Axim Biotech has 301,958,830 shares outstanding.
What happened to Axim Biotech’s price movement after its last earnings report?
Axim Biotech reported an EPS of -$0.01 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of Axim Biotech?
Currently, no hedge funds are holding shares in AXIM
---
Company Description
Axim Biotech
AXIM Biotechnologies, Inc. is engaged in the research, development, and production of pharmaceutical, nutraceutical, cosmetic, and genetically controlled botanical products. It also involves in the extraction and purification of cannabinoids technologies based on its proprietary technologies. Its products include CBD-based controlled release chewing gum under CanChew brand; and a combination of CBD and THC gum that treats pain and spasticity associated with multiple sclerosis under MedChew Rx brand. The company was founded on November 18, 2010 and is headquartered in New York, NY.
---
---